157 related articles for article (PubMed ID: 10947246)
1. Reduction of syndecan-1 expression is associated with dysplastic oral epithelium.
Soukka T; Pohjola J; Inki P; Happonen RP
J Oral Pathol Med; 2000 Aug; 29(7):308-13. PubMed ID: 10947246
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
3. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
[TBL] [Abstract][Full Text] [Related]
4. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
5. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of syndecan-1 in oral dysplastic epithelium.
Lakkam B; Majage B; Astekar M; Gugwad RS; Giri G; Ramasahayam S
J Cancer Res Ther; 2014; 10(1):103-6. PubMed ID: 24762495
[TBL] [Abstract][Full Text] [Related]
7. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity.
Jackson LL; Wade Z; Hessler RB; Abdelsayed R; Rogers JB; Gourin CG
Laryngoscope; 2007 May; 117(5):868-71. PubMed ID: 17473685
[TBL] [Abstract][Full Text] [Related]
9. Syndecan in carcinomas produced from transformed epithelial cells in nude mice.
Inki P; Kujari H; Jalkanen M
Lab Invest; 1992 Mar; 66(3):314-23. PubMed ID: 1538586
[TBL] [Abstract][Full Text] [Related]
10. High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery.
Anttonen A; Heikkilä P; Kajanti M; Jalkanen M; Joensuu H
Lung Cancer; 2001 Jun; 32(3):297-305. PubMed ID: 11390011
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma.
Bayer-Garner IB; Sanderson RD; Smoller BR
J Cutan Pathol; 1999 Sep; 26(8):386-90. PubMed ID: 10551410
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma.
Wakulich C; Jackson-Boeters L; Daley TD; Wysocki GP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):573-9. PubMed ID: 12075207
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation.
Inki P; Stenbäck F; Talve L; Jalkanen M
Am J Pathol; 1991 Dec; 139(6):1333-40. PubMed ID: 1750507
[TBL] [Abstract][Full Text] [Related]
14. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma.
Bayer-Garner IB; Smoller BR
J Cutan Pathol; 2001 Feb; 28(2):83-9. PubMed ID: 11168756
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Tilakaratne WM; Kobayashi T; Ida-Yonemochi H; Swelam W; Yamazaki M; Mikami T; Alvarado CG; Shahidul AM; Maruyama S; Cheng J; Saku T
J Oral Pathol Med; 2009 Apr; 38(4):348-55. PubMed ID: 19239574
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity.
Devoll RE; Li W; Woods KV; Pinero GJ; Butler WT; Farach-Carson MC; Happonen RP
J Oral Pathol Med; 1999 Mar; 28(3):97-101. PubMed ID: 10069535
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.
Funayama A; Cheng J; Maruyama S; Yamazaki M; Kobayashi T; Syafriadi M; Kundu S; Shingaki S; Saito C; Saku T
Pathobiology; 2011; 78(3):171-80. PubMed ID: 21613804
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix.
Inki P; Stenbäck F; Grenman S; Jalkanen M
J Pathol; 1994 Apr; 172(4):349-55. PubMed ID: 8207616
[TBL] [Abstract][Full Text] [Related]
19. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.
Inki P; Joensuu H; Grénman R; Klemi P; Jalkanen M
Br J Cancer; 1994 Aug; 70(2):319-23. PubMed ID: 8054282
[TBL] [Abstract][Full Text] [Related]
20. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
